dynatronics.com (DYNT) Long-Term Liabilities to Equity

Corporate emblem and logo of Dynatronics (DYNT)

The growth of Dynatronics Corporation (DYNT) relies on updating its product line and managing costs while maintaining acceptable liquidity, which constitutes 0.00. This chart of current share prices complements the analysis of the brand's operations in producing rehabilitation tools. Medical center loyalty to proven technologies ensures sustained demand, while established distribution channels in hospitals guarantee the annual stability of sales for core consumables.

DYNT dynatronics.com: Long-Term Debt to Capital in the range 07/04/2022 - 08/04/2024
Manufactured product of Dynatronics Corp

Low levels of long-term liabilities minimize bankruptcy risk in the event of a sharp rise in interest rates. Stable demand from rehabilitation centers for Dynatronics Corporation (DYNT) equipment ensures a predictable cash flow for debt servicing. This metric compares the amount of loans with a term exceeding one year against equity to determine the degree of financial autonomy. By analyzing the ratio of long-term loans to equity, an investor assesses the stability of the financing structure. The stability of this curve confirms a conservative approach to borrowing.

Key competitors

Boston Scientific Corp (BSX) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Edwards Lifesciences Corp (EW)|RMD: Long-Term Liabilities to Equity|Long-Term Debt to Capital PODD (Insulet Corporation)|Zimmer (ZBH) - Long-Term Liabilities to Capital|CooperCompanies - Long-Term Debt to Capital|Invisalign (ALGN) - Long-Term Debt to Equity Ratio|GMED: Long-Term Debt to Capital|TMDX - Ratio of Long-Term Indebtedness to Capital|ATEC (Alphatec Holdings, Inc.) - Long-Term Debt to Capital|Long-Term Debt to Capital artivion.com|Long-Term Debt to Equity Enovis (ENOV)|Long-Term Debt to Equity IART (Integra LifeSciences Corp)|Long-Term Debt to Capital ESTA (Motiva)|Ratio of Long-Term Indebtedness to Capital iLet Bionic Pancreas (BBNX)|IRMD: Long-Term Debt to Equity Ratio|Long-Term Liabilities to Equity EMBC|TNDM: Long-Term Debt to Capital|Long-Term Liabilities to Capital AxoGen Inc (AXGN)|SIBN (SI-BONE Corp) - Long-Term Debt to Capital|Long-Term Debt to Capital Ratio OFIX (Orthofix Corp)|Long-Term Debt to Equity Ratio BVS (Bioventus Inc.)|KIDS (orthopediatrics.com) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Equity Treace Medical Concepts, Inc. TMCI|SRTA - Long-Term Debt to Equity Ratio|Carlsmed Corp - Long-Term Debt to Capital|Long-Term Liabilities to Capital RxSight Ophthalmic|CLPT: Long-Term Debt to Capital|Long-Term Debt to Capital Ratio STXS|STIM (Neuronetics) - Long-Term Debt to Capital|Sight Sciences Inc. (SGHT) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Capital OBIO|Long-Term Debt to Equity Ratio anikatherapeutics.com ANIK|Long-Term Debt to Capital NSPR (InspireMD, Inc.)|Long-Term Debt to Capital Jin Medical International Ltd. ZJYL|VANI - Long-Term Debt to Equity|XTNT: Long-Term Debt to Equity|NMTC (NeuroOne Corp) - Long-Term Debt to Equity Ratio|Modular Medical, Inc. - Long-Term Debt to Capital Coefficient|MYO (Myomo, Inc.) - Long-Term Debt to Capital|Long-Term Liabilities to Capital envoymedical.com COCH|Long-Term Debt to Equity Vivos Therapeutics, Inc. (VVOS)|enVVeno Medical Corporation (NVNO) - Long-Term Indebtedness to Equity|Sintx Technologies, Inc. - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Tenon Medical Inc TNON|ReWalk Robotics Ltd. - Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital Autonomix Medical, Inc. AMIX|INVO Fertility (IVF) - Long-Term Debt to Equity|Long-Term Liabilities to Equity BBLG (Bone Biologics Corp.)|Long-Term Debt to Equity Axonics Modulation Technologies|Long-Term Debt to Equity Ratio Biolase Inc. (BIOL)|Long-Term Debt to Capital FNA|INVO - Long-Term Liabilities to Capital